Cargando…

Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus

DNA vaccines offer promising strategies for immunization against infections. However, their clinical use requires improvements in immunogenicity. We explored the efficacy of Toll-like receptor (TLR) ligands (TLR-Ls) on augmenting the immunogenicity of a DNA prime–modified vaccinia virus Ankara (MVA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwissa, Marcin, Amara, Rama R., Robinson, Harriet L., Moss, Bernard, Alkan, Sefik, Jabbar, Abdul, Villinger, Francois, Pulendran, Bali
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2007
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118478/ https://www.ncbi.nlm.nih.gov/pubmed/17954572 http://dx.doi.org/10.1084/jem.20071211

Ejemplares similares

Prevention of Peripheral Tolerance by a Dendritic Cell Growth Factor: Flt3 Ligand as an Adjuvant
por: Pulendran, Bali, et al.
Publicado: (1998)

BacSp222 bacteriocin as a novel ligand for TLR2/TLR6 heterodimer
por: Śmiałek-Bartyzel, Justyna, et al.
Publicado: (2023)

Upregulation of Fas Ligand by Simian Immunodeficiency Virus—A nef-arious Mechanism of Immune Evasion?
por: Johnson, R. Paul
Publicado: (1997)

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
por: Querec, Troy, et al.
Publicado: (2006)

Peptide crosslinked micelles: a new strategy for the design and synthesis of peptide vaccines
por: Hao, Jihua, et al.
Publicado: (2006)

Further Activation of FLT3 Mutants by FLT3 Ligand
por: Zheng, Rui, et al.
Publicado: (2011)

Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
por: Gregg, Kelsey A., et al.
Publicado: (2017)

Effects of an ActRIIB.Fc Ligand Trap on Cardiac Function in Simian Immunodeficiency Virus-Infected Male Rhesus Macaques
por: Guo, Wen, et al.
Publicado: (2018)

Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
por: Chamcha, Venkateswarlu, et al.
Publicado: (2016)

Functional MAIT Cells Are Associated With Reduced Simian–Human Immunodeficiency Virus Infection
por: Murugesan, Amudhan, et al.
Publicado: (2020)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Abundance of Flt3 and its ligand in astrocytic tumors
por: Eßbach, C, et al.
Publicado: (2013)

The Cytokine Flt3-Ligand in Normal and Malignant Hematopoiesis
por: Tsapogas, Panagiotis, et al.
Publicado: (2017)

Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques
por: Bollimpelli, Venkata S., et al.
Publicado: (2023)

pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG
por: Wu, Jing, et al.
Publicado: (2019)

Attenuation of vaccinia virus by the expression of human Flt3 ligand
por: Zurkova, Kamila, et al.
Publicado: (2010)

Emerging concepts in the science of vaccine adjuvants
por: Pulendran, Bali, et al.
Publicado: (2021)

Wild‐type FLT3 and FLT3 ITD exhibit similar ligand‐induced internalization characteristics
por: Kellner, Fabienne, et al.
Publicado: (2020)

Innate Immunity in Simian Immunodeficiency Virus Infection
por: Reeves, Roger Keith, et al.
Publicado: (2014)

Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells
por: Xu, Xiao-Ning, et al.
Publicado: (1997)

Engineering and crystal structure of a monomeric FLT3 ligand variant
por: Pannecoucke, Erwin, et al.
Publicado: (2021)

Chemokine Adjuvanted Electroporated-DNA Vaccine Induces Substantial Protection from Simian Immunodeficiency Virus Vaginal Challenge
por: Kutzler, M A, et al.
Publicado: (2015)

Silencing SOCS1 via Liposome-Packed siRNA Sustains TLR4-Ligand Adjuvant
por: Hildebrand, Dagmar, et al.
Publicado: (2019)

Divergent HIV and Simian Immunodeficiency Virus Surveillance, Zaire
por: Schaefer, Amanda, et al.
Publicado: (2005)

Central African Hunters Exposed to Simian Immunodeficiency Virus
por: Kalish, Marcia L., et al.
Publicado: (2005)

Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics
por: Vaidya, Naveen K., et al.
Publicado: (2016)

Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques
por: Xiao, Peng, et al.
Publicado: (2022)

T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian- human immunodeficiency virus
Publicado: (1995)

Flt3 Ligand Regulates Dendritic Cell Development from Flt3(+) Lymphoid and Myeloid-committed Progenitors to Flt3(+) Dendritic Cells In Vivo
por: Karsunky, Holger, et al.
Publicado: (2003)

Intrathymic expression of Flt3 ligand enhances thymic recovery after irradiation
por: Kenins, Linda, et al.
Publicado: (2008)

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
por: Herbert, Megan K., et al.
Publicado: (2015)

Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus Infection
por: Veazey, Ronald S., et al.
Publicado: (2003)

Dual inhibition of AKT/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML
por: Wang, Aoli, et al.
Publicado: (2016)

The molecular basis for recognition of bacterial ligands at equine TLR2, TLR1 and TLR6
por: Irvine, Katherine Lucy, et al.
Publicado: (2013)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Impact of Simian Immunodeficiency Virus Infection on Chimpanzee Population Dynamics
por: Rudicell, Rebecca S., et al.
Publicado: (2010)

Simian-Human Immunodeficiency Infection – Is the Course Set in the Acute Phase?
por: Petravic, Janka, et al.
Publicado: (2011)

Mapping the Small RNA Content of Simian Immunodeficiency Virions (SIV)
por: Brameier, Markus, et al.
Publicado: (2013)

Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas
por: Barbian, Hannah J., et al.
Publicado: (2015)

Lymphatic Dissemination of Simian Immunodeficiency Virus after Penile Inoculation
por: Ma, Zhong-Min, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k4hdtoqvdd0nl7oigiln61of4v